150 related articles for article (PubMed ID: 32688220)
21. Towards Optimizing Risk-adapted Treatment of APML in ATRA/ATO Era: How Can Prediction of Early Mortality Help?
Buhtoiarov IN
J Pediatr Hematol Oncol; 2021 May; 43(4):158. PubMed ID: 33625082
[No Abstract] [Full Text] [Related]
22. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).
Fujita H; Ishikawa Y; Yokoyama Y
Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422
[No Abstract] [Full Text] [Related]
23. [A neonate born to a mother with acute promyelocytic leukemia treated by all-trans retinoic acid].
Maeda M; Tyugu H; Okubo T; Yamamoto M; Nakamura K; Dan K
Rinsho Ketsueki; 1997 Sep; 38(9):770-5. PubMed ID: 9364869
[TBL] [Abstract][Full Text] [Related]
24. Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.
Rhee JY; Tremblay D; Chan AM; Tallman MS; Mascarenhas J
Blood Adv; 2019 Jun; 3(12):1854-1857. PubMed ID: 31213431
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin.
Lin CP; Huang MJ; Liu HJ; Chang IY; Tsai CH
Am J Hematol; 1996 Mar; 51(3):251-2. PubMed ID: 8619417
[No Abstract] [Full Text] [Related]
26. [Successful treatment of acute promyelocytic leukemia in a pregnant woman by using all-trans retinoic acid].
Tsuda H; Doi H; Inada T; Shirono K
Rinsho Ketsueki; 1994 Jul; 35(7):717-9. PubMed ID: 8065028
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
[TBL] [Abstract][Full Text] [Related]
28. Treatment of acute promyelocytic leukemia with all-trans retinoic acid during the third trimester of pregnancy.
Watanabe R; Okamoto S; Moriki T; Kizaki M; Kawai Y; Ikeda Y
Am J Hematol; 1995 Mar; 48(3):210-1. PubMed ID: 7864036
[No Abstract] [Full Text] [Related]
29. All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia.
Simone MD; Stasi R; Venditti A; Del Poeta G; Aronica G; Bruno A; Masi M; Tribalto M; Papa G; Amadori S
Leukemia; 1995 Aug; 9(8):1412-3. PubMed ID: 7643633
[No Abstract] [Full Text] [Related]
30. Successful use of all-trans retinoic acid in acute promyelocytic leukaemia presenting during the second trimester of pregnancy.
Harrison P; Chipping P; Fothergill GA
Br J Haematol; 1994 Mar; 86(3):681-2. PubMed ID: 8043456
[TBL] [Abstract][Full Text] [Related]
31. [Acute promyelocytic leukaemia].
Tøstesen M; Østergård LSG; Kjeldsen E; Stentoft J; Nørgaard JM
Ugeskr Laeger; 2018 Jan; 180(3):. PubMed ID: 29336301
[TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
Stentoft J; Nielsen JL; Hvidman LE
Leukemia; 1994 Sep; 8(9):1585-8. PubMed ID: 8090035
[TBL] [Abstract][Full Text] [Related]
33. The economic research of arsenic trioxide for the treatment of newly diagnosed acute promyelocytic leukemia in China.
Chen X; Hong Y; Zheng P; You X; Feng J; Huang Z; Wang Y
Cancer; 2020 Jan; 126(2):311-321. PubMed ID: 31714584
[TBL] [Abstract][Full Text] [Related]
34. Flexural Eruption Associated With Arsenic Trioxide Therapy in a Patient With Acute Promyelocytic Leukemia.
Teran VA; Wilson BB; Guffey DJ
JAMA Dermatol; 2019 Mar; 155(3):389-391. PubMed ID: 30673070
[No Abstract] [Full Text] [Related]
35. The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
Zhu HH; Guo ZP; Jia JS; Jiang Q; Jiang H; Huang XJ
Leuk Res; 2018 Feb; 65():14-19. PubMed ID: 29232592
[TBL] [Abstract][Full Text] [Related]
36. Molecular remission without blood product support using all-trans retinoic acid (ATRA) induction and combined arsenic trioxide/ATRA consolidation in a Jehovah's Witness with de novo acute promyelocytic leukaemia.
Kennedy GA; Marlton P; Cobcroft R; Gill D
Br J Haematol; 2000 Dec; 111(4):1103-5. PubMed ID: 11167746
[TBL] [Abstract][Full Text] [Related]
37. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
38. All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Iland HJ; Bradstock K; Supple SG; Catalano A; Collins M; Hertzberg M; Browett P; Grigg A; Firkin F; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF;
Blood; 2012 Aug; 120(8):1570-80; quiz 1752. PubMed ID: 22715121
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of acute promyelocytic leukemia in pregnancy with all-trans retinoic acid.
Fadilah SA; Hatta AZ; Keng CS; Jamil MA; Singh S
Leukemia; 2001 Oct; 15(10):1665-6. PubMed ID: 11587228
[No Abstract] [Full Text] [Related]
40. Microgranular variant of acute promyelocytic leukemia with cytoplasmic projections resembling micromegakaryocytes.
Jiang W; Lee SH
Blood; 2018 Nov; 132(21):2314. PubMed ID: 30467190
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
